WHO pours cold water on Gilead’s Covid drug remdesivir

The only drug with full Food and Drug Administration approval to treat Covid-19 patients is getting dissed by the World Health Organization. A panel of 28 clinical care experts, four patient-partners and one ethicist said Foster City-based Gilead Sciences Inc.'s antiviral drug remdesivir — branded as Veklury — offers no evidence that it improves survival for Covid patients, reduces the need for ventilation, time to clinical improvement and other standards. The panel conditionally recommended…

Click to view original post